Infectious Disease Advisor news story
Sarcopenic obesity affects an estimated 8% of people with HIV (PWH), although prevalence varies considerably depending on the criteria used to define the condition, according to study results published in the Journal of Obesity.
Long-term antiretroviral therapy (ART) has extended survival among PWH, increasing the importance of age-related changes in muscle and adipose tissue. However, identifying sarcopenic obesity in this population can be challenging because HIV and its treatment may alter fat distribution and body composition in ways that are not adequately captured by diagnostic thresholds established in populations without HIV.
Researchers conducted a scoping review and exploratory meta-analysis to examine how sarcopenic obesity has been identified among adults with HIV and to estimate its prevalence.
Read the full news story here.
/Infectious Disease Advisor requires free registration if more than 5 articles are viewed per month/
Source : Infectious Disease Advisor
Related HIV and Co-Infections News
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.